News
New research reveals progress in Neurodegenerative disease approaches
Survey highlights the benefit of physical and mathematical sciences, new platforms and AI modelling techniques to improve understanding of neurodegenerative diseases of the brain.
The Charterhouse Rheumatism Charity and ongoing research into rheumatology and musculoskeletal medicine.
The Charterhouse Rheumatism Charity (the Charity) was established in 1936 to continue the work of the Charterhouse Rheumatism Clinic.
'Remarkable' results in colon cancer trial
Giving colon cancer patients chemotherapy before surgery cuts the risk of the disease coming back, according to the results of a new clinical trial.
New Lancet Rheumatology paper shows low risk of severe outcomes from Rituximab use for patients who receive COVID and Booster vaccination
Patients taking an immunosuppressant drug for rheumatic and musculoskeletal diseases do not appear to be at higher risk of serious outcomes from COVID-19 infection as long as they are vaccinated.
Scientists find genetic ‘marker’ linked to serious side-effects from skin cancer treatment
New research has identified a genetic marker that could be used to predict a patient’s risk of developing serious side-effects when undergoing immunotherapy treatment for metastatic melanoma.